Literature DB >> 15922662

Immunobiology of muscle: advances in understanding an immunological microenvironment.

Heinz Wiendl1, Reinhard Hohlfeld, Bernd C Kieseier.   

Abstract

Skeletal muscle, which is the largest cellular compartment of the body, lacks detectable MHC expression under physiological conditions. Therefore, immune reactions triggered by, or directed against, muscle cells proceed along specific pathways. Recently, the expression and functioning of classical MHC, non-classical MHC, adhesion and co-stimulatory molecules have been shown to support the concept that muscle cells can act as facultative antigen-presenting cells and should be considered as active participants, rather than passive targets, of immune reactions. Here, we summarize current knowledge on the immunological capabilities of skeletal muscle cells and discuss how these characteristics might contribute to inflammatory muscle disorders, as well as therapeutic strategies, such as gene or myoblast transfer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922662     DOI: 10.1016/j.it.2005.05.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  41 in total

Review 1.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

Review 2.  The Bacterial Ghost platform system: production and applications.

Authors:  Timo Langemann; Verena Juliana Koller; Abbas Muhammad; Pavol Kudela; Ulrike Beate Mayr; Werner Lubitz
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

Review 3.  Immunotherapy of myositis: issues, concerns and future prospects.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Rheumatol       Date:  2010-02-02       Impact factor: 20.543

4.  Regulatory T Cells Promote Myositis and Muscle Damage in Toxoplasma gondii Infection.

Authors:  Richard M Jin; Sarah J Blair; Jordan Warunek; Reid R Heffner; Ira J Blader; Elizabeth A Wohlfert
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

5.  Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.

Authors:  N A Goyal; T M Cash; U Alam; S Enam; P Tierney; N Araujo; F H Mozaffar; A Pestronk; T Mozaffar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-09       Impact factor: 10.154

6.  Transcriptomic response of skeletal muscle to lipopolysaccharide in the gilthead seabream (Sparus aurata).

Authors:  Elisavet Kaitetzidou; Diego Crespo; Yoryia Vraskou; Efthimia Antonopoulou; Josep V Planas
Journal:  Mar Biotechnol (NY)       Date:  2012-07-24       Impact factor: 3.619

7.  Immunotherapy of inflammatory myopathies: practical approach and future prospects.

Authors:  Marinos C Dalakas
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

8.  Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2.

Authors:  Qi Liu; Fuwu Wang; Guan Wang; Qunli Zhao; Juan Min; Shuai Wang; Hua Cong; Ying Li; Shenyi He; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

Review 9.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

10.  Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage.

Authors:  Elena Rigamonti; Thierry Touvier; Emilio Clementi; Angelo A Manfredi; Silvia Brunelli; Patrizia Rovere-Querini
Journal:  J Immunol       Date:  2013-01-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.